CAJ | 학술논문

目的探讨过氧化物酶体增殖物活化受体γ(PPARγ)的配体罗格列酮(RGZ)与全反式维甲酸(ATRA)对骨髓瘤细胞分化的影响及其可能机制.方法以RGZ和ATRA处理人骨髓瘤细胞U266和RPMI-8226,用~3H-掺入法检测细胞增殖变化;碘化丙啶(PI)染色后,以流式细胞仪检测细胞周期变化;瑞氏-姬母萨染色观察细胞形态学变化;流式细胞仪分析细胞表面CD49e的表达变化;Western blot方法检测p27~(k1p1)和p21~(Wafl)的表达变化.结果 RGZ能显著抑制U266和RPMI-8226细胞的增殖,并且这种抑制作用呈剂量依赖性.经5 μmol/L RGZ处理后,U266和RPMI-8226细胞G_0/G_1期细胞的比例分别为(45.2±6.7)%和(40.3±7.3)%,较对照组明显增加(均P<0.05);G_2/M期和S期细胞的比例分别为(52.2±7.4)%和(57.4±9.5)%,较对照组明显减少(均P<0.05);CD49e的表达率分别为(8.7±1.5)%和(7.9±1.6)%,较对照组明显上调(均P<0.05).以10μmol/L RGZ处理后,U266和RPMI-8226细胞的G_0/G_1期、G_2/M期和S期细胞比例、CD49e的表达率均较5μmol/LRGZ组的变化更加显著.同时,经RGZ处理后,U266和RPMI-8226细胞的形态学变化也符合骨髓瘤细胞分化成熟的规律,p27~(kipl)和p21~(Wafl)蛋白的表达量也较对照组明显增加.RGZ和ATRA联合对U266和RPMI-8226细胞影响较RGZ单独作用更加明显.结论 RGZ可能通过上调p27~(kipl)和p21~(Wafl)蛋白的表达,介导骨髓瘤细胞的周期阻滞,并诱导骨髓瘤细胞分化,抑制骨髓瘤细胞增殖.ATRA能增强RGZ对骨髓瘤细胞的上述作用,两者联合具有协同效应.
목적 탐토과양화물매체증식물활화수체γ(PPARγ)적배체라격렬동(RGZ)여전반식유갑산(ATRA)대골수류세포분화적영향급기가능궤제.방법 이RGZ화ATRA처리인골수류세포U266화RPMI-8226,용~3H-참입법검측세포증식변화;전화병정(PI)염색후,이류식세포의검측세포주기변화;서씨-희모살염색관찰세포형태학변화;류식세포의분석세포표면CD49e적표체변화;Western blot방법검측p27~(k1p1)화p21~(Wafl)적표체변화.결과 RGZ능현저억제U266화RPMI-8226세포적증식,병차저충억제작용정제량의뢰성.경5 μmol/L RGZ처리후,U266화RPMI-8226세포G_0/G_1기세포적비례분별위(45.2±6.7)%화(40.3±7.3)%,교대조조명현증가(균P<0.05);G_2/M기화S기세포적비례분별위(52.2±7.4)%화(57.4±9.5)%,교대조조명현감소(균P<0.05);CD49e적표체솔분별위(8.7±1.5)%화(7.9±1.6)%,교대조조명현상조(균P<0.05).이10μmol/L RGZ처리후,U266화RPMI-8226세포적G_0/G_1기、G_2/M기화S기세포비례、CD49e적표체솔균교5μmol/LRGZ조적변화경가현저.동시,경RGZ처리후,U266화RPMI-8226세포적형태학변화야부합골수류세포분화성숙적규률,p27~(kipl)화p21~(Wafl)단백적표체량야교대조조명현증가.RGZ화ATRA연합대U266화RPMI-8226세포영향교RGZ단독작용경가명현.결론 RGZ가능통과상조p27~(kipl)화p21~(Wafl)단백적표체,개도골수류세포적주기조체,병유도골수류세포분화,억제골수류세포증식.ATRA능증강RGZ대골수류세포적상술작용,량자연합구유협동효응.
Objective To investigate the effects of PPARγ ligand(rosiglitazone,RGZ)as well as combined with all trans-retinoic acid(ATRA)on human myeloma cells and try to explore the possible mechanism.Methods Human myeloma cell lines U266 and RPMl.8226 cells were treated with RGZ in the presence or absence of ATRA.Cell proliferation was evaluated by [~3H] thymidine incorporation,cell cycle distribution and CD49e expression were analyzed by flow cytometry,morphology changes were evaluated by Wright-Giemsa staining.and p27~(Klpl)and p21~(Wafl)expression was detected by Western blotting.Results The exposure to RGZ induced proliferation inhibifion in both cell Iines in a dose-dependent manner.After cultured with 5 μmol/L RGZ,the proportion of U266 and RPMl-8226 cells in phase G_0/G_1 was(45.2±6.7)%and(40.3±7.3)%,respectively(P<0.05).The proportion of the cells in phase G_2/M and Swag(52.2±7.4)%and(57.4±9.5)%,respectively(P<0.05).These changes were more evident when the RGZ concentration was increased to 10 μmol/L.A combination of RGZ with ATRA enhanced the growth inhibition and eell cycle arrest effects of RGZ.The RGZ-treated myeloma cells displayed morphological characteristics of cell difierentiation.and more evident signs of differentiation were observed when RGZ wag combined with ATRA.These changes were confirmed by the detection of CD49e expression.The expression of p27~(Klpl)and p21~(Wafl)in myeloma cells was up-regulated by RGZ and this change Was more apparent when RGZ was used in combination with ATRA.Conclusion RGZ Can induce cell cycle arrest and cell differentiation in myeloma cells which maybe caused by up-regulation of p27~(Klpl)and p21~(Wafl)expression.ATRA can enhance these effects of RGZ on multiple myeloma cells and combined nile of thesetwo drugs may show a synergistic effect on myeloma cells.